Gonorrhea Figures
ShareCompartir
This web page is archived for historical purposes and is no longer being updated. Newer data is available on the
Figure 11. Gonorrhea — Rates of Reported Cases by Year, United States, 1941–2013
Figure 12. Gonorrhea — Rates of Reported Cases by Sex, United States, 1993–2013
Figure 13. Gonorrhea — Rates of Reported Cases by Region, United States, 2004–2013
Figure 14. Gonorrhea — Rates of Reported Cases by State, United States and Outlying Areas, 2013
Figure 15. Gonorrhea — Rates of Reported Cases by County, United States, 2013
Figure 16. Gonorrhea — Rates of Reported Cases by Age and Sex, United States, 2013
Figure 17. Gonorrhea — Rates of Reported Cases Among Women Aged 15–44 Years by Age, United States, 2004–2013
Figure 18. Gonorrhea — Rates of Reported Cases Among Men Aged 15–44 Years by Age, United States, 2004–2013
Figure 19. Gonorrhea — Rates of Reported Cases by Race/Ethnicity, United States, 2009–2013
Figure 20. Gonorrhea — Reported Cases by Reporting Source and Sex, United States, 2004–2013
Figure 21. Gonorrhea — Percentage of Reported Cases by Sex and Reporting Source, United States, 2013
Figure 22. Estimated Proportion of MSM, MSW, and Women Among Gonorrhea Cases by Site, STD Surveillance Network (SSuN), 2013
Figure 23. Gonorrhea — Proportion of STD Clinic Patients Testing Positive by Age, Sex, and Sexual Behavior, STD Surveillance Network (SSuN), 2013
Figure 24. Location of Participating Sentinel Sites and Regional Laboratories, Gonoccoccal Isolate Surveillance Project (GISP), United States, 2013
Figure 25. Neisseria gonorrhoeae — Percentage of Isolates with Elevated Ceftriaxone Minimum Inhibitory Concentrations (MICs) (≥0.125 µg/ml), Gonococcal Isolate Surveillance Project (GISP), 2006–2013
Figure 26. Neisseria gonorrhoeae — Percentage of Isolates with Elevated Cefixime Minimum Inhibitory Concentrations (MICs) (≥0.25 µg/ml), Gonococcal Isolate Surveillance Project (GISP), 2005–2013
Figure 27. Neisseria gonorrhoeae — Distribution of Azithromycin Minimum Inhibitory Concentrations (MICs), Gonococcal Isolate Surveillance Project (GISP), 2009–2013
Figure 28. Neisseria gonorrhoeae — Percentage of Isolates with Penicillin, Tetracycline, and/or Ciprofloxacin Resistance, Gonococcal Isolate Surveillance Project (GISP), 2013
Figure 29. Primary Antimicrobial Drugs Used to Treat Gonorrhea Among Participants, Gonococcal Isolate Surveillance Project (GISP), 1988–2013
- Page last reviewed: December 16, 2014 (archived document)
- Content source: